O1^Q0,HRKXT5N$:2$!+M';MKZIX
SYSTEM PROCESSING...
O1^Q0,HRKXT5N$:2$!+M';MKZIX
SYSTEM PROCESSING...
Posted: 2025-04-25 04:31:08 UTC
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
This article contains some claims that are falsified. While not everything in the article is false, please proceed with extreme caution and verify any critical information independently.
Status
Last Updated
2025-04-25 04:44:33 UTC
Verified By
Rollup News
Unity Biotechnology's research, published in NEJM Evidence, suggests that senolytic therapeutics can provide long-term vision improvements in Diabetic Macular Edema (DME) by clearing senescent cells in the retina.
Senolytic therapeutics
Vision improvement
Diabetic Macular Edema (DME)
Clearing senescent cells
Long-term effects
Developing effective senolytic drugs
Ensuring long-term safety and efficacy
Addressing the underlying causes of DME